Skip to main content
CYTOKINETICS INC logo

CYTOKINETICS INC — Investor Relations & Filings

Ticker · CYTK ISIN · US23282W6057 LEI · 549300BE5DY1HW7IHA64 US Manufacturing
Open in API
Filings indexed 1,760 across all filing types
Latest filing 2026-05-27 Share Issue/Capital Cha…
Country US United States of America
Listing US CYTK

About CYTOKINETICS INC

https://cytokinetics.com/

Cytokinetics is a late-stage biopharmaceutical company that specializes in muscle biology and the mechanics of muscle performance. The company focuses on discovering, developing, and commercializing small molecule drug candidates engineered to impact muscle function and contractility. Its primary therapeutic areas include debilitating cardiovascular and neuromuscular diseases, such as heart failure and hypertrophic cardiomyopathy (HCM). Cytokinetics' pipeline is centered on developing first-in-class muscle activators and next-in-class muscle inhibitors, with a significant focus on cardiac myosin inhibitors. The company's mission is to improve the healthspan of patients living with conditions of impaired muscle function.

Recent filings

Filing Released Lang Actions
S-8
Share Issue/Capital Change Classification · 85% confidence The document is a full SEC Registration Statement on Form S-8 filed by Cytokinetics, Inc. to register an additional 1,000,000 shares of common stock under the Amended and Restated 2015 Employee Stock Purchase Plan. This pertains to the registration and issuance of new shares under an employee plan, which constitutes a capital change. Therefore, it best fits the Share Issue/Capital Change category (SHA).
2026-05-27 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a Form 8-K “Item 5.07 Submission of Matters to a Vote of Security Holders” that provides the detailed vote counts for proposals at the Annual Meeting held May 27, 2026. This is an official announcement of voting results at a shareholder meeting, matching the definition of “Declaration of Voting Results & Voting Rights Announcements (DVA).”
2026-05-27 English
424B5 - CYTOKINETICS INC (0001061983) (Filer)
Share Issue/Capital Change Classification · 85% confidence The document is a Form 424B5 prospectus supplement to a shelf registration under SEC Rule 424(b)(5), detailing the terms of an offering of 9,859,155 shares of common stock, underwriting arrangements, pricing, use of proceeds, and related capital‐raising details. This is a direct announcement of a new share issue and capital change, not a report on financial results or regulatory attestation. Accordingly, it fits the “Share Issue/Capital Change” category (Code: SHA).
2026-05-07 English
8-K - CYTOKINETICS INC (0001061983) (Filer)
Report Publication Announcement Classification · 87% confidence The document is a Form 8-K current report that does not itself include substantive financial or operational data but simply announces that the company’s corporate presentation is attached as Exhibit 99.1. Under the “Menu vs Meal” rule, this is an announcement of the publication of a report (“the presentation is attached”), rather than the report content itself. That matches the definition of a Report Publication Announcement (RPA).
2026-05-05 English
ARS - CYTOKINETICS INC (0001061983) (Filer)
Annual Report
2026-04-17 English
DEF 14A - CYTOKINETICS INC (0001061983) (Filer)
Proxy Solicitation & Information Statement
2026-04-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.